{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:46:53Z","timestamp":1787028413649,"version":"build-2736575974"},"reference-count":38,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,4,14]],"date-time":"2019-04-14T00:00:00Z","timestamp":1555200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The incidence of aging-related disorders may be decreased through strategies influencing the expression of longevity genes. Although numerous approaches have been suggested, no effective, safe, and easily applicable approach is yet available. Efficacy of low-dose fluvastatin and valsartan, separately or in combination, on the expression of the longevity genes in middle-aged males, was assessed. Stored blood samples from 130 apparently healthy middle-aged males treated with fluvastatin (10 mg daily), valsartan (20 mg daily), fluvastatin-valsartan combination (10 and 20 mg, respectively), and placebo (control) were analyzed. They were taken before and after 30 days of treatment and, additionally, five months after treatment discontinuation. The expression of the following longevity genes was assessed: SIRT1, PRKAA, KLOTHO, NFE2L2, mTOR, and NF-\u03baB. Treatment with fluvastatin and valsartan in combination significantly increased the expression of SIRT1 (1.8-fold; p &lt; 0.0001), PRKAA (1.5-fold; p = 0.262) and KLOTHO (1.7-fold; p &lt; 0.0001), but not NFE2L2, mTOR and NF-\u03baB. Both fluvastatin and valsartan alone significantly, but to a lesser extent, increased the expression of SIRT1, and did not influence the expression of other genes. Five months after treatment discontinuation, genes expression decreased to the basal levels. In addition, analysis with previously obtained results revealed significant correlation between SIRT1 and both increased telomerase activity and improved arterial wall characteristics. We showed that low-dose fluvastatin and valsartan, separately and in combination, substantially increase expression of SIRT1, PRKAA, and KLOTHO genes, which may be attributed to their so far unreported pleiotropic beneficial effects. This approach could be used for prevention of ageing (and longevity genes)\u2013related disorders.<\/jats:p>","DOI":"10.3390\/ijms20081844","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T11:15:58Z","timestamp":1555326958000},"page":"1844","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent\/Treat \u201cAging-Related Disorders\u201d"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7073-8922","authenticated-orcid":false,"given":"Miodrag","family":"Jani\u0107","sequence":"first","affiliation":[{"name":"Department of Vascular Diseases, Ljubljana University Medical Centre, Zalo\u0161ka cesta 7, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Lunder","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases, Ljubljana University Medical Centre, Zalo\u0161ka cesta 7, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srdjan","family":"Novakovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnostics, Institute of Oncology Ljubljana, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"\u0160kerl","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnostics, Institute of Oncology Ljubljana, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0161o","family":"\u0160abovi\u010d","sequence":"additional","affiliation":[{"name":"Department of Vascular Diseases, Ljubljana University Medical Centre, Zalo\u0161ka cesta 7, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Stevens, W., Peneva, D., Li, J.Z., Liu, L.Z., Liu, G., Gao, R., and Lakdawalla, D.N. (2016). Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv. Res., 16.","DOI":"10.1186\/s12913-016-1420-8"},{"key":"ref_2","unstructured":"Global Burden of Cardiovascular Diseases Collaboration, Roth, G.A., Johnson, C.O., Abate, K.H., Abd-Allah, F., Ahmed, M., Alam, K., Alam, T., Alvis-Guzman, N., and Ansari, H. (2018). The Burden of Cardiovascular Diseases Among US States, 1990\u20132016. JAMA Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Van Raamsdonk, J.M. (2017). Mechanisms underlying longevity: A genetic switch model of aging. Exp. Gerontol.","DOI":"10.1016\/j.exger.2017.08.005"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1874609808666150122153151","article-title":"Telomere length variations in aging and age-related diseases","volume":"7","author":"Rizvi","year":"2014","journal-title":"Curr. Aging Sci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yeh, J.K., and Wang, C.Y. (2016). Telomeres and Telomerase in Cardiovascular Diseases. Genes, 7.","DOI":"10.3390\/genes7090058"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.mehy.2013.03.028","article-title":"A new anti-ageing strategy focused on prevention of arterial ageing in the middle-aged population","volume":"80","author":"Janic","year":"2013","journal-title":"Med. Hypotheses"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2010.12.041","article-title":"Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males\u2014A pilot study","volume":"215","author":"Lunder","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1177\/1741826711423104","article-title":"Reduction of age-associated arterial wall changes by low-dose valsartan","volume":"19","author":"Lunder","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejim.2011.11.011","article-title":"The effects of low-dose fluvastatin and valsartan combination on arterial function: A randomized clinical trial","volume":"23","author":"Lunder","year":"2012","journal-title":"Eur. J. Int. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/rej.2015.1722","article-title":"Low-Dose Fluvastatin and Valsartan Rejuvenate the Arterial Wall Through Telomerase Activity Increase in Middle-Aged Men","volume":"19","author":"Janic","year":"2016","journal-title":"Rejuvenation Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/HCR.0000000000000027","article-title":"A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males","volume":"34","author":"Janic","year":"2014","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s10059-013-0130-x","article-title":"Do sirtuins promote mammalian longevity? A critical review on its relevance to the longevity effect induced by calorie restriction","volume":"35","author":"Park","year":"2013","journal-title":"Mol. Cells"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/YCO.0b013e32835112c1","article-title":"Sirtuins in cognitive ageing and Alzheimer\u2019s disease","volume":"25","author":"Braidy","year":"2012","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3892\/ijmm.2014.1740","article-title":"Simvastatin attenuates TNF\u03b1-induced apoptosis in endothelial progenitor cells via the upregulation of SIRT1","volume":"34","author":"Du","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/1440-1681.12362","article-title":"Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: The role of sirtuin 1 gene variants in human coronary atherosclerosis","volume":"42","author":"Kilic","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10557-011-6339-z","article-title":"Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice","volume":"25","author":"Ye","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1475-2840-11-139","article-title":"Telmisartan ameliorates insulin sensitivity by activating the AMPK\/SIRT1 pathway in skeletal muscle of obese db\/db mice","volume":"11","author":"Shiota","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.3748\/wjg.v21.i26.8021","article-title":"Losartan activates sirtuin 1 in rat reduced-size orthotopic liver transplantation","volume":"21","author":"Pantazi","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.febslet.2010.11.047","article-title":"SIRT1 and AMPK in regulating mammalian senescence: A critical review and a working model","volume":"585","author":"Wang","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1755-5922.2011.00287.x","article-title":"Atorvastatin inhibits homocysteine-induced endoplasmic reticulum stress through activation of AMP-activated protein kinase","volume":"30","author":"Jia","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1161\/CIRCULATIONAHA.106.630194","article-title":"Statins activate AMP-activated protein kinase in vitro and in vivo","volume":"114","author":"Sun","year":"2006","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/cvr\/cvt070","article-title":"HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome","volume":"99","author":"Hermida","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/jcmm.12354","article-title":"Valsartan independent of AT(1) receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions","volume":"18","author":"Ha","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2015.01.037","article-title":"Telmisartan enhances mitochondrial activity and alters cellular functions in human coronary artery endothelial cells via AMP-activated protein kinase pathway","volume":"239","author":"Kurokawa","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4331\/wjbc.v6.i4.351","article-title":"Klotho in cardiovascular disease: Current and future perspectives","volume":"6","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2215\/CJN.02700313","article-title":"Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria","volume":"8","author":"Karalliedde","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1159\/000342117","article-title":"Statin upregulates the expression of KLOTHO, an anti-aging gene, in experimental cyclosporine nephropathy","volume":"120","author":"Yoon","year":"2012","journal-title":"Nephron. Exp. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"9237263","DOI":"10.1155\/2017\/9237263","article-title":"The Role of Nrf2 in Cardiovascular Function and Disease","volume":"2017","author":"Satta","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Hwang, A.R., Han, J.H., Lim, J.H., Kang, Y.J., and Woo, C.H. (2017). Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178278"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2010.07.059","article-title":"Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway","volume":"213","author":"Makabe","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","article-title":"Mammalian target of rapamycin signaling in cardiac physiology and disease","volume":"114","author":"Sciarretta","year":"2014","journal-title":"Circ. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1159\/000457881","article-title":"Protective Effects of Fluvastatin on Reproductive Function in Obese Male Rats Induced by High-Fat Diet through Enhanced Signaling of mTOR","volume":"41","author":"Cui","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"C119","DOI":"10.1152\/ajpcell.00429.2009","article-title":"Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR","volume":"299","author":"Wagner","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3892\/mmr.2013.1708","article-title":"Induction of autophagy contributes to the myocardial protection of valsartan against ischemiareperfusion injury","volume":"8","author":"Wu","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1113\/JP270538","article-title":"Ageing, metabolism and cardiovascular disease","volume":"594","author":"Costantino","year":"2016","journal-title":"J. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"720987","DOI":"10.1155\/2014\/720987","article-title":"Statin treatment is associated with reduction in serum levels of receptor activator of NF-\u03baB ligand and neutrophil activation in patients with severe carotid stenosis","volume":"2014","author":"Lenglet","year":"2014","journal-title":"Mediators Inflamm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2013.02.036","article-title":"Valsartan attenuates oxidative stress and NF-\u03baB activation and reduces myocardial apoptosis after ischemia and reperfusion","volume":"705","author":"Wu","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u2206\u2206Ct Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/8\/1844\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:45:21Z","timestamp":1760186721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/8\/1844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,14]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["ijms20081844"],"URL":"https:\/\/doi.org\/10.3390\/ijms20081844","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,14]]}}}